| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $67.67M | $57.88M | $36.27M | $52.12M | $33.05M |
| Cost of Revenue | – | – | – | – | $0.00 |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $388.86M | $466.31M | $435.07M | $419.98M | $229.81M |
| SG&A | $119.80M | $125.83M | $116.50M | $90.31M | $71.10M |
| Operating Income | -$440.99M | -$534.26M | -$515.29M | -$458.16M | -$267.85M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$412.69M | -$519.02M | -$481.19M | -$474.19M | -$267.89M |
| EPS (basic) | -3.8100 | -5.2500 | -5.4200 | -6.1600 | -3.7800 |
| EPS (diluted) | -3.8100 | -5.2500 | -5.4200 | -6.1600 | -3.7800 |
| Shares (diluted) | $108.38M | $98.85M | $88.77M | $76.97M | $70.89M |